BeiGene, Ltd.

Ownership Transactions Reported by 24 Insiders

Symbol
BGNE on Nasdaq, BEIGF on OTC
Industry
Pharmaceutical Preparations
Location
C/O Mourant Governance Services (Cayman), 94 Solaris Avenue, Camana Bay, Grand Cayman, Cayman Islands

Insiders trading volume in the past year

BeiGene, Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Hhlr Advisors, Ltd. 10%+ Owner $29.7B Jun 13, 2023
Amgen Inc 10%+ Owner $3.42B Sep 10, 2021
Baker Bros. Advisors Lp Director, 10%+ Owner $1.46B Jun 5, 2024
Xiaodong Wang Director, Chair, Scientific Advisory Brd $1.09B Aug 12, 2024
Donald W. Glazer Director $565M Jun 5, 2024
John Oyler Chief Executive Officer, Director $370M -$20.2M -5.19% Oct 8, 2024
Lai Wang Global Head of R&D $357M -$1.64M -0.46% Sep 27, 2024
Howard Liang CFO & Chief Strategy Officer $323M Jun 28, 2021
Xiaobin Wu President, COO & GM China $223M -$2.79M -1.23% Sep 17, 2024
Julia Aijun Wang Chief Financial Officer $88.6M -$420K -0.47% Jul 1, 2024
Chan Henry Lee SVP, General Counsel $49.3M -$489K -0.98% Sep 30, 2024
Jane Huang CMO, Hematology $33.2M Dec 14, 2021
Aaron Rosenberg Chief Financial Officer $24.6M Aug 9, 2024
Thomas Malley Director $15.1M Jun 15, 2023
Anthony C. Hooper Director $11.2M Jun 5, 2024
Corazon (. D. Sanders Director $9.61M Jun 5, 2024
Titus B. Ball Principal Accounting Officer $9.58M -$26K -0.27% Sep 3, 2024
Alessandro Riva Director $9.55M Jun 5, 2024
Qingqing Yi Director $9.55M Jun 5, 2024
Margaret Dugan Director $9.55M Jun 5, 2024
Olivier Brandicourt Director $3.39M Jun 5, 2024
Shalini Sharp Director $1.69M Sep 30, 2024
Jingshyh S. su Director $1.62M Jun 16, 2021
Timothy Yung-Cheng Chen Director $1.62M Jun 16, 2021

Recent Insider Transactions by Companies or Individuals for BeiGene, Ltd.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.